Salibay, Baby Girl .
HRN: 26-64-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2025
AMPICILLIN 500MG (VIAL)
02/06/2025
02/13/2025
INTRAVENOUS
35 Mg
Every 12 Hours
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes